The administration of
tumor necrosis factor-alpha (
TNF-alpha) or the anti-Fas antibody (Jo-2) to mice causes
acute liver failure, which is lethal within hours as a result of the induction of apoptosis in hepatocytes. It was recently reported that nonobese diabetic (NOD) mice are less sensitive to
TNF-alpha/D-
galactosamine (GalN)-induced
liver failure than C57BL/6J (B6) mice, whereas both NOD and B6 mice were sensitive to the lethal effect of Jo-2. In the present study, we investigated the differences between the apoptotic liver cell death induced by
TNF-alpha/GalN and that induced by Jo-2. B6, NOD, and Jcl-Imperial
Cancer Research (ICR) mice were injected intravenously with
TNF-alpha/GalN or Jo-2. ICR mice were less sensitive to
TNF-alpha/GalN-induced
liver failure than NOD and B6 mice (P<0.0001). In contrast, ICR mice were more sensitive to Jo-2-induced
liver failure than B6 mice (P=0.0003). The liver
caspase-3, -8 activity, serum
transaminase levels, and the number of apoptotic liver nuclei all decreased in ICR in comparison to B6 mice treated with
TNF-alpha/GalN. The
mRNA expression of TNFR-associated death domain, Fas associated
protein with death domain, and Bcl family and
nuclear factor-kappaB activation induced by
TNF-alpha/GalN were similar in both mice. Interestingly, the short form of cellular FLICE/
caspase-8-inhibitory
protein (c-
FLIP(S)) was constitutively upregulated in ICR mice. In conclusion, these results suggest that ICR mice have an intrinsic resistance to
TNF-alpha-induced hepatocyte apoptosis, and that c-
FLIP(S) may play a role in
TNF-alpha/GalN-induced
liver failure, but not in Fas-induced
liver failure.